Protecting American Families and Servicemembers from Anthrax Act
In Committee
Introduced:Aug 12, 2025
Primary Sponsor
Donald Gene Davis
Representative
Democratic
NC-1
Cosponsors
13
Quick Stats
Policy Area
Health
Summary
This bill aims to encourage pharmaceutical and medical manufacturing in economically distressed areas by providing tax credits to companies located in these zones. It aims to boost production of important drugs, medical devices, and personal protective equipment within the United States.
Latest Action
Referred to the Subcommittee on Health.
AI Summary
Plain-English explanation of this bill
This bill aims to encourage pharmaceutical and medical manufacturing in economically distressed areas by providing tax credits to companies located in these zones. It aims to boost production of important drugs, medical devices, and personal protective equipment within the United States.
Last updated: 12/30/2025
Official Summary
Congressional Research Service summary
<p><b>Manufacturing API, Drugs, and Excipients in America Act or the MADE in America Act</b></p> <p>This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products.</p> <p>Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone. </p> <p>The bill defines <i>distressed zone </i>as an area that has been designated as a qualified opportunity zone by the Internal Revenue Service (i.e., an economically distressed community in which certain new investments may be eligible for preferential tax treatment) and that has a poverty rate of over 30%.</p>
Key Points
Main provisions of the bill
Establishes a tax credit of 25% for manufacturers of pharmaceuticals, medical products, and personal protective equipment located in designated distressed zones.
The tax credit increases to 30% if a substantial portion of the manufacturer's employees reside in the distressed zone.
Defines 'distressed zone' as an area designated as a qualified opportunity zone by the IRS with a poverty rate over 30%.
Intended to boost domestic production of critical medical supplies and reduce reliance on foreign imports.
Could incentivize companies to open or expand facilities in economically disadvantaged communities.
How This Impacts Americans
Potential effects on citizens and communities
If passed, this bill would primarily impact pharmaceutical and medical manufacturing companies, as well as residents of economically distressed communities where these facilities are located. It could lead to new job opportunities and investment in underserved areas, while also aiming to strengthen the domestic supply of important drugs and medical products.
Policy Areas
Primary Policy Area
Health
Scope & Jurisdiction
Jurisdiction Level
federal
Congressional Session
119th Congress
Citation Reference
2707, 119th Congress (2025). "Protecting American Families and Servicemembers from Anthrax Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-2707
